John Sperzel is the President, Chief Executive Officer, and member of the Board of Directors at T2 Biosystems, a leader in the rapid detection of sepsis-causing pathogens. After surviving an acute, life-threatening illness that resulted in a heart transplant, John is passionate about advancing life-saving technologies.

​

Professional Life

Prior to T2 Biosystems, John served as President, CEO, and Board member at Chembio Diagnostics, Inc., a leading point-of-care diagnostics company focused on infectious diseases, and as President, CEO, and Board member at ITC Medical, a point-of-care diagnostics company owned by Warburg Pincus. Previously, John held executive and commercial leadership positions at Axis-Shield (Abbott), Bayer Diagnostics (Siemens), Instrumentation Laboratory, and Boehringer  Mannheim (Roche).

​

John earned a Bachelor of Science in Business/Management from Plymouth State University.

 

"I started out simply by following my passion, and paired it with my strengths and unique genius, and over time gained, honed and built my skill set through experience At that point in my career—at the intersection of passion, talent, and experience—I truly felt unstoppable."